REYZDIVI
LIVE

Serial Number

99119116

Owner

Pfizer Inc.

Attorney

Heather A. McDonald

Filing Date

Apr 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

REYZDIVI Trademark

Serial Number: 99119116

REYZDIVI is a trademark filed by Pfizer Inc. on April 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Pfizer Inc. (36 trademarks)

66 Hudson Boulevard East
New York, NY 10001-2192

Entity Type: 03

Trademark Details

Filing Date

April 3, 2025

Registration Date

Not Registered

Published for Opposition

January 13, 2026

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 10, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 3, 2025 MAFR
NEW APPLICATION ENTERED
Apr 3, 2025 NWAP